P. Laure, Epidemiologic approach of doping in sport. A review, J Sports Med Phys Fitness, vol.37, issue.3, pp.218-242, 1997.

P. Simon, H. Striegel, F. Aust, K. Dietz, and R. Ulrich, Doping in fitness sports: estimated number of unreported cases and individual probability of doping, Addiction, vol.101, issue.11, pp.1640-1644, 2006.

C. Raschka, C. Chmiel, R. Preiss, and C. Boos, Recreational athletes and doping, a survey in 11 gyms in the area of Frankfurt/Main, MMW Fortschr Med, vol.155, issue.2, pp.41-44, 2013.

M. J. Haerinejad, A. Ostovar, M. R. Farzaneh, and M. Keshavarz, The prevalence and characteristics of performance-enhancing drug use among bodybuilding athletes in the south of Iran, Bushehr. Asian J Sports Med, vol.7, issue.3, 2016.

H. Angoorani and F. Halabchi, The misuse of anabolic-androgenic steroids among Iranian recreational male body-builders and their related psycho-socio-demographic factors, Iran J Public Health, vol.44, issue.12, pp.1662-1671, 2015.

C. Tsitsimpikou, N. Chrisostomou, P. Papalexis, K. Tsarouhas, A. Tsatsakis et al., The use of nutritional supplements among recreational athletes in Athens, Greece, Int J Sport Nutr Exerc Metab, vol.21, issue.5, pp.377-84, 2011.

H. Striegel, P. Simon, S. Frisch, K. Roecker, K. Dietz et al., Anabolic ergogenic substance users in fitness-sports: A distinct group supported by the health care system, Drug Alcohol Depend, vol.81, issue.1, pp.11-20, 2006.

S. Nogueira-fr-de, F. Brito-a-de, C. Oliveira, . De, T. I. Vieira et al., Anabolicandrogenic steroid use among Brazilian bodybuilders, Subst Use Misuse, vol.49, issue.9, pp.1138-1183, 2014.

Z. Razavi, B. Moeini, Y. Shafiei, and H. Bazmamoun, Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, western province of Iran, J Res Health Sci, vol.14, issue.2, pp.163-169, 2014.

M. Lindström, A. L. Nilsson, P. L. Katzman, L. Janzon, and J. F. Dymling, Use of anabolicandrogenic steroids among body builders-frequency and attitudes, J Intern Med, vol.227, issue.6, pp.407-418, 1990.

J. Karimian and P. S. Esfahani, Supplement consumption in body builder athletes, J Res Med Sci Off J Isfahan Univ Med Sci, vol.16, issue.10, pp.1347-53, 2011.

G. Sepehri, M. Fard, M. Sepehri, and E. , Frequency of anabolic steroids abuse in bodybuilder athletes in Kerman city, Addict Health, vol.1, issue.1, pp.25-34, 2009.

A. Agence-mondiale, Liste des Interdictions, vol.9, 2016.

A. Momaya, M. Fawal, and R. Estes, Performance-enhancing substances in sports: a review of the literature, Sports Med Auckl NZ, vol.45, issue.4, pp.517-548, 2015.

H. G. Pope, R. I. Wood, A. Rogol, F. Nyberg, L. Bowers et al., Adverse health consequences of performance-enhancing drugs: an endocrine society scientific statement, Endocr Rev, vol.35, issue.3, pp.341-75, 2014.
DOI : 10.1210/er.2013-1058

URL : https://academic.oup.com/edrv/article-pdf/35/3/341/8863240/edrv0341.pdf

P. Gardiner, D. Sarma, T. Low-dog, M. Barrett, M. Chavez et al., The state of dietary supplement adverse event reporting in the United States, Pharmacoepidemiol Drug Saf, vol.17, issue.10, pp.962-70, 2008.

A. , Avis de l'Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail relatif aux risques liés à la consommation de compléments alimentaires destinés aux sportifs visant le développement musculaire ou la diminution de la masse grasse

. Maisons-alfort, , 2016.

, Code du sport-Article L232-3

. Code-du-sport and . Disponible,

P. Laure, Doping in sport: doctors are providing drugs, Br J Sports Med, vol.31, issue.3, pp.258-267, 1997.
DOI : 10.1136/bjsm.31.3.258-b

URL : https://bjsm.bmj.com/content/31/3/258.3.full.pdf

S. H. Backhouse and J. Mckenna, Doping in sport: a review of medical practitioners' knowledge, attitudes and beliefs, Int J Drug Policy, vol.22, issue.3, pp.198-202, 2011.

V. Scarpino, A. Arrigo, G. Benzi, S. Garattini, L. Vecchia et al., Evaluation of prevalence of « doping » among Italian athletes, Lancet, vol.336, issue.8722, pp.1048-50, 1990.

P. Greenway and M. Greenway, General practitioner knowledge of prohibited substances in sport, Br J Sports Med, vol.31, issue.2, pp.129-160, 1997.

P. Laure, C. Binsinger, and T. Lecerf, General practitioners and doping in sport: attitudes and experience, Br J Sports Med, vol.37, issue.4, pp.335-343, 2003.
DOI : 10.1136/bjsm.37.4.335

URL : https://bjsm.bmj.com/content/37/4/335.full.pdf

C. B. Woods and A. Moynihan, General practitioners knowledge, practice and training requirements in relation to doping in sport, Ir Med J, vol.102, issue.1, pp.8-10, 2009.

V. Lentillon-kaestner and F. Ohl, Can we measure accurately the prevalence of doping?, J Med Sci Sports, vol.21, issue.6, pp.132-174, 2011.

D. Oswald and C. J. Le-dopage-dans-le-sport, État des lieux et nouvelles perspectives, vol.1

D. Hauw, . Psychologie-du-dopage.-de-boeck, and . Supérieur,

P. Laure, Doping: epidemiological studies. Presse Médicale Paris Fr, vol.29, pp.1365-72, 1983.

J. Sobal and L. F. Marquart, Vitamin/mineral supplement use among athletes: a review of the literature, Int J Sport Nutr, vol.4, issue.4, pp.320-354, 1994.

H. G. Pope, G. Kanayama, M. Ionescu-pioggia, and J. I. Hudson, Anabolic steroid users' attitudes towards physicians, Addict Abingdon Engl, vol.99, issue.9, pp.1189-94, 2004.

B. P. Brennan, G. Kanayama, and H. G. Pope, Performance-enhancing drugs on the web: a growing public-health issue, Am J Addict, vol.22, issue.2, pp.158-61, 2013.

C. Raschka and N. Draßner, Epidemiology of doping in rural gyms in the district of Traunstein, MMW Fortschr Med, vol.157, issue.5, pp.5-8, 2015.

J. L. Goston and M. Correia, Intake of nutritional supplements among people exercising in gyms and influencing factors, Nutr Burbank Los Angel Cty Calif, vol.26, issue.6, pp.604-615, 2010.

A. Ehrenberg, Le culte de la performance, Calmann-Levy
URL : https://hal.archives-ouvertes.fr/halshs-00585599

E. Durkheim, Les règles de la méthodologie sociologique

P. Laure, Histoire du dopage et des conduites dopantes: Les alchimistes de la performance

P. Bacquaert, . Le-dopage, and . Son-histoire,

I. , Disponible sur, 2016.

M. Lee, The history of Ephedra (ma-huang), J R Coll Physicians Edinb, vol.41, pp.78-84, 2011.

D. Allais and . Le-ginseng, Actual Pharm, vol.485, pp.45-53, 2009.

B. Thouvenin, Coca et cocaïne : De l'usage traditionnel à l'addiction, 2012.

C. Paleologos, Légendes d, Olympie. Rev Olymp, pp.66-67, 1973.

Y. Tranvouez and . Henri, Dict Biogr Frères Prêch Dominic Prov Fr XIXe-XXe Siècles, 2015.

F. Zimniuch, Crooked: A History of Cheating in Sports, 2009.

L. Albert, Les forçats de la route, Arléa

M. Jean-pierre, Dopage: L'imposture des performances, Mensonges et vérités sur l'histoire de la triche

Y. Bordenave, B. Hopquin, L. Coeur, and P. , UCI a couvert Lance Armstrong dès le Tour 1999. lemonde.fr

, Discovery Channel. Lance Armstrong on Oprah Part, 2013.

R. Mclaren, WADA Investigation of Sochi Allegations, p.97, 2016.

P. Laure, Dopage et société. Ellipses. Paris, vol.447, 2000.

. , Tendant à la répression des stimulants à l'occasion des compétitions sportives, 1965.

, Décret n°66-373 du 10 juin 1966 portant règlement d'administration publique pour l'application de la loi N°65-412 du 1er juin 1965 tendant à la répression de l'usage des stimulants à l'occasion des compétitions sportives

G. Le-moan, Le dopage des intellectuels et des sportifs, Prod Prob Pharm, issue.22, pp.5-15, 1967.

. , juin 1989 relative à la répression du dopage des animaux participant à des manifestations et compétitions sportives

A. Agence-mondiale, , 2016.

A. Agence-mondiale, Liste des Interdictions, p.9, 2016.

. , du 23 mars 1999 relative à la protection de la santé des sportifs et à la lutte contre le dopage, pp.99-223

. , 405 du 5 avril 2006 relative à la lutte contre le dopage et à la protection de la santé des sportifs, vol.6, p.5193, 2006.

. Agence-française-de-lutte-contre-le-dopage, Effectuer une demande d'AUT

. Disponible,

, Décret n° 2016-1157 du 24 août 2016 relatif au certificat médical attestant de l'absence de contre-indication à la pratique du sport

/. ,

, Avis relatif à la sécurité des salles de remise en forme

E. Pdf,

D. Hauw, . Psychologie-du-dopage.-de-boeck, and . Supérieur,

V. Lentillon-kaestner and F. Ohl, Can we measure accurately the prevalence of doping?, J Med Sci Sports, vol.21, issue.6, pp.132-174, 2011.

. Agence-française-de-luttre-contre-le-dopage,

P. Laure, Epidemiologic approach of doping in sport. A review, J Sports Med Phys Fitness, vol.37, issue.3, pp.218-242, 1997.

P. Laure, Doping: epidemiological studies. Presse Médicale Paris Fr, vol.29, pp.1365-72, 1983.

C. Raschka and N. Draßner, Epidemiology of doping in rural gyms in the district of Traunstein, MMW Fortschr Med, vol.157, issue.5, pp.5-8, 2015.

P. Simon, H. Striegel, F. Aust, K. Dietz, and R. Ulrich, Doping in fitness sports: estimated number of unreported cases and individual probability of doping, Addiction, vol.101, issue.11, pp.1640-1644, 2006.

C. Raschka, C. Chmiel, R. Preiss, and C. Boos, Recreational athletes and doping, a survey in 11 gyms in the area of Frankfurt/Main, MMW Fortschr Med, vol.155, issue.2, pp.41-44, 2013.

M. J. Haerinejad, A. Ostovar, M. R. Farzaneh, and M. Keshavarz, The prevalence and characteristics of performance-enhancing drug use among bodybuilding athletes in the south of Iran, Bushehr. Asian J Sports Med, vol.7, issue.3, 2016.

H. Angoorani and F. Halabchi, The misuse of anabolic-androgenic steroids among Iranian recreational male body-builders and their related psycho-socio-demographic factors, Iran J Public Health, vol.44, issue.12, pp.1662-1671, 2015.

C. Tsitsimpikou, N. Chrisostomou, P. Papalexis, K. Tsarouhas, A. Tsatsakis et al., The use of nutritional supplements among recreational athletes in Athens, Greece, Int J Sport Nutr Exerc Metab, vol.21, issue.5, pp.377-84, 2011.

H. Striegel, P. Simon, S. Frisch, K. Roecker, K. Dietz et al., Anabolic ergogenic substance users in fitness-sports: A distinct group supported by the health care system, Drug Alcohol Depend, vol.81, issue.1, pp.11-20, 2006.

S. Nogueira-fr-de, F. Brito-a-de, C. Oliveira, . De, T. I. Vieira et al., Anabolicandrogenic steroid use among Brazilian bodybuilders, Subst Use Misuse, vol.49, issue.9, pp.1138-1183, 2014.

Z. Razavi, B. Moeini, Y. Shafiei, and H. Bazmamoun, Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, western province of Iran, J Res Health Sci, vol.14, issue.2, pp.163-169, 2014.

M. Lindström, A. L. Nilsson, P. L. Katzman, L. Janzon, and J. F. Dymling, Use of anabolicandrogenic steroids among body builders-frequency and attitudes, J Intern Med, vol.227, issue.6, pp.407-418, 1990.

J. Karimian and P. S. Esfahani, Supplement consumption in body builder athletes, J Res Med Sci Off J Isfahan Univ Med Sci, vol.16, issue.10, pp.1347-53, 2011.

S. Didier, Automédication chez les coureurs de trail et d'ultra-trail: Enquête lors de l'infernal Trail des Vosges, 2014.

P. Laure, T. Lecerf, A. Friser, and C. Binsinger, Drugs, recreational drug use and attitudes towards doping of high school athletes, Int J Sports Med, vol.25, issue.2, pp.133-141, 2004.

J. Sobal and L. F. Marquart, Vitamin/mineral supplement use among athletes: a review of the literature, Int J Sport Nutr, vol.4, issue.4, pp.320-354, 1994.

T. A. Mcguine, J. C. Sullivan, and D. A. Bernhardt, Creatine supplementation in Wisconsin high school athletes, WMJ Off Publ State Med Soc Wis, vol.101, issue.2, pp.25-30, 2002.

G. Sepehri, M. Fard, M. Sepehri, and E. , Frequency of anabolic steroids abuse in bodybuilder athletes in Kerman city, Addict Health, vol.1, issue.1, pp.25-34, 2009.

A. Ghobain, M. Konbaz, M. S. Almassad, A. Alsultan, A. et al., knowledge and attitude of prohibited substances use (doping) among Saudi sport players, Subst Abuse Treat Prev Policy, vol.11, p.14, 2016.

J. L. Goston and M. Correia, Intake of nutritional supplements among people exercising in gyms and influencing factors, Nutr Burbank Los Angel Cty Calif, vol.26, issue.6, pp.604-615, 2010.

, Fédération nationale des observatoires régionaux de santé. Étude qualitative sur les représentations concernant le dopage et sa prévention chez les sportifs et leur entourage

. Paris, Disponible sur, p.374, 2014.

H. G. Pope, G. Kanayama, M. Ionescu-pioggia, and J. I. Hudson, Anabolic steroid users' attitudes towards physicians, Addict Abingdon Engl, vol.99, issue.9, pp.1189-94, 2004.

S. H. Backhouse and J. Mckenna, Doping in sport: a review of medical practitioners' knowledge, attitudes and beliefs, Int J Drug Policy, vol.22, issue.3, pp.198-202, 2011.

P. Laure, C. Binsinger, and T. Lecerf, General practitioners and doping in sport: attitudes and experience, Br J Sports Med, vol.37, issue.4, pp.335-343, 2003.

C. B. Woods and A. Moynihan, General practitioners knowledge, practice and training requirements in relation to doping in sport, Ir Med J, vol.102, issue.1, pp.8-10, 2009.

G. Panagiotis, D. Ourania, C. F. Jannis, and P. S. , Knowledge on and attitudes of doping in sport, of young trainees in internal and general-familial medicine, Pharmacologyonline, vol.2, pp.1-5, 2006.

Y. Allem, Évaluation des connaissances du médecin généraliste sur le dopage, p.87, 2008.

J. De-mondenard,

A. Momaya, M. Fawal, and R. Estes, Performance-enhancing substances in sports: a review of the literature, Sports Med Auckl NZ, vol.45, issue.4, pp.517-548, 2015.

H. G. Pope, R. I. Wood, A. Rogol, F. Nyberg, L. Bowers et al., Adverse health consequences of performance-enhancing drugs: an endocrine society scientific statement, Endocr Rev, vol.35, issue.3, pp.341-75, 2014.

P. Gardiner, D. Sarma, T. Low-dog, M. Barrett, M. Chavez et al., The state of dietary supplement adverse event reporting in the United States, Pharmacoepidemiol Drug Saf, vol.17, issue.10, pp.962-70, 2008.

J. Woo, Adverse event monitoring and multivitamin-multimineral dietary supplements, Am J Clin Nutr, vol.85, issue.1, pp.323-327, 2007.

A. , Avis de l'Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail relatif aux risques liés à la consommation de compléments alimentaires destinés aux sportifs visant le développement musculaire ou la diminution de la masse grasse

. Maisons-alfort, , 2016.

K. R. Sargrad, C. Homko, M. Mozzoli, and G. Boden, Effect of high protein vs high carbohydrate intake on insulin sensitivity, body weight, hemoglobin A1c, and blood pressure in patients with type 2 diabetes mellitus, J Am Diet Assoc, vol.105, issue.4, pp.573-80, 2005.

A. N. Friedman, L. G. Ogden, G. D. Foster, S. Klein, R. Stein et al., Comparative effects of low-carbohydrate high-protein versus low-fat diets on the kidney, Clin J Am Soc Nephrol, vol.7, issue.7, pp.1103-1114, 2012.

E. L. Knight, M. J. Stampfer, S. E. Hankinson, D. Spiegelman, and G. C. Curhan, The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency, Ann Intern Med, vol.138, issue.6, pp.460-467, 2003.

R. C. Harris, M. J. Tallon, M. Dunnett, L. Boobis, J. Coakley et al., The absorption of orally supplied beta-alanine and its effect on muscle carnosine synthesis in human vastus lateralis, Amino Acids, vol.30, issue.3, pp.279-89, 2006.

S. P. Schulman, L. C. Becker, D. A. Kass, H. C. Champion, M. L. Terrin et al., Larginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial, JAMA, vol.295, issue.1, pp.58-64, 2006.

, glycérol et l'administration intraveineuse d'albumine, dextran, hydroxyéthylamidon et mannitol.-Acétazolamide ; amiloride ; bumétanide ; canrénone ; chlortalidone ; acide étacrynique ; furosémide ; indapamide ; métolazone ; spironolactone ; thiazides, par ex. bendrofluméthiazide, chlorothiazide, et hydrochlorothiazide ; triamtérène et vaptans, par ex. tolvaptan. Sauf :-la drospirénone

, de n'importe quelle quantité des substances qui suivent étant soumises à un niveau seuil : formotérol, salbutamol, cathine, éphédrine, méthyléphédrine et pseudoéphédrine, conjointement avec un diurétique ou un agent masquant, sera consideré comment un résultat d'analyse anormal (RAA) sauf si le sportif a une autorisation d'usage à des fins thérapeutiques (AUT) approuvée pour cette substance